Providers need a flexible and scalable approach to cardiac Telemetry that gives them the acuity, agility, and adaptability required to deliver top-notch treatment in any location as virtual care becomes a permanent role in healthcare. Although the healthcare sector is hardly new to remote care, its prevalence intensified during the coronavirus.

The trends indicate that telemedicine is here to stay in 2023 and beyond. Infobionic Inc has always been at the forefront of the latest trends in the healthcare sector. Precisely, the firm has always been focused on enhancing the cardiac telemetry scenario. InfoBionic aims to create the first mobile cardiac telemetry technology that can be used anywhere that virtual care is provided and support any level of acuity. “When InfoBionic was founded more than a decade ago, we reimagined accepted mobile cardiac arrhythmia detection norms with a full disclosure model built upon the principles of unwavering quality and continual innovation.

Today, we’re carrying those same pillars forward as we make yet another bold foray into the future of healthcare,” says Stuart Long, Chief Executive Office. Providers need new care and reimbursement models without losing sight of their patients as healthcare continues its virtual, value-based makeover. In addition, Telemetry must adjust to accommodate this brand-new healthcare environment. Infobionic has always been attentive toward similar core concerns of the industry. The enterprise relies heavily on its MoMe ARC Platform to achieve the intended results.

WHY INFOBIONIC?

The enterprise is the source of solutions that are first-inclass and transformative. Remote arrhythmia monitoring and diagnosis are examples of how the cardiac care sector associates itself with virtual models. In these times, virtual models are of extreme importance due to their potential for frequent use in several disciplines in cardiology. “Built with the same standards of quality that have earned us the trust of cardiology leaders, our flexible platform will hand power back to clinicians while enabling them to embrace virtual care with full confidence,” informs Stuart Long.

To make more accurate diagnoses and control cardiac arrhythmia detection and monitoring processes, in-depth data insights are enabled at every stage. A straightforward assessment considerably improves patient satisfaction and compliance while saving time by preventing follow-up visits. It is also possible to control all reporting required to maximize diagnosis accuracy and make quicker decisions.

THE MOME™ ARC PLATFORM

The MoMe ARC Platform has always been a differentiator for Infobionic Inc. Providers can customize the MoMe ARC Platform to almost any clinical use case with complete trust in the full disclosure methodology that has set InfoBionic apart from the beginning. “We see the MoMe ARC platform as the only platform on the market capable of supporting the full spectrum of acuity required in a virtual care world.

Built with the same standards of quality that have earned us the trust of cardiology leaders, our flexible platform will hand power back to clinicians while enabling them to embrace virtual care with full confidence,” adds the CEO. The MoMe ARC Platform makes better data access possible, which also improves workflow effectiveness and practice management for remote cardiac Telemetry. As a result, improve the quality of your care to new heights.